Physician profile
Mark Zekaj
NPI 1457745416
$11,091.92
in general payments reported to CMS, 2019-2025
8 companies · $6,728 in 2025
The $6,728 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $92.67 · 2021: $1,622 · 2022: $1,091 · 2023: $192 · 2024: $1,367 · 2025: $6,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,380 · Travel and Lodging: $1,228 · Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,380.00 |
| Travel and Lodging | $1,227.78 |
| Food and Beverage | $678.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $8,757.10 | 2021-2025 | Rosa, Avenir, Persona |
| Stryker Corporation | $1,320.74 | 2020-2023 | Mako |
| Depuy Synthes Sales INC. | $615.08 | 2022 | |
| Smith+Nephew, INC. | $165.43 | 2025 | Redapt, Pico 7 |
| Medical Device Business Services, INC. | $94.81 | 2022 | |
| Medtronic, INC. | $72.48 | 2021 | |
| Solventum Corporation | $46.71 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, Prevena Restor Arthroform |
| Next Science LLC | $19.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Zekaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.